Advertisement
UK markets close in 54 minutes
  • FTSE 100

    8,391.43
    +37.38 (+0.45%)
     
  • FTSE 250

    20,548.06
    +56.07 (+0.27%)
     
  • AIM

    783.15
    +3.32 (+0.43%)
     
  • GBP/EUR

    1.1607
    -0.0016 (-0.13%)
     
  • GBP/USD

    1.2515
    +0.0018 (+0.14%)
     
  • Bitcoin GBP

    48,991.91
    -888.84 (-1.78%)
     
  • CMC Crypto 200

    1,320.11
    +20.01 (+1.54%)
     
  • S&P 500

    5,199.65
    +11.98 (+0.23%)
     
  • DOW

    39,230.24
    +173.85 (+0.45%)
     
  • CRUDE OIL

    79.44
    +0.45 (+0.57%)
     
  • GOLD FUTURES

    2,344.40
    +22.10 (+0.95%)
     
  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     
  • HANG SENG

    18,537.81
    +223.95 (+1.22%)
     
  • DAX

    18,680.60
    +182.22 (+0.99%)
     
  • CAC 40

    8,183.55
    +52.14 (+0.64%)
     

Remdesivir becomes first coronavirus drug to get FDA approval

One vial of the drug Remdesivir which has now received FDA approval (POOL/AFP via Getty Images)
One vial of the drug Remdesivir which has now received FDA approval (POOL/AFP via Getty Images)

Remdesivir is the first antiviral medicine to receive approval from the Food and Drug Administration (FDA).

US regulators signed off on Thursday on the drug, which is given to hospitalised patients through an IV.

The drug has been authorized to be used in case of emergency since early in the pandemic but is the first treatment to win full approval from the FDA.

President Trump received the treatment after he contracted Covid-19 earlier this month and was hospitalized at Walter Reed Medical Center in Bethesda, Maryland.

The drug has been named Veklury by creators, the California-based Gilead Sciences. The treatment has cut recovery time by five days - from 15 days to 10 on average - according to a large study led by the National Institutes of Health.

Read more

‘Dramatic’ surge in Covid forces hospital to cancel operations

Why are there so many outbreaks at meat factories?

How cruises will change after coronavirus